How Does Acetazolamide (Diamox) Work for IIH?
At a Glance
Acetazolamide (Diamox) treats Idiopathic Intracranial Hypertension (IIH) by targeting the brain's choroid plexus to slow the production of cerebrospinal fluid. This decrease in fluid volume directly lowers the abnormally high pressure inside the skull to help protect your vision.
In this answer
4 sections
Acetazolamide (commonly known by the brand name Diamox) helps treat Idiopathic Intracranial Hypertension (IIH) by slowing down how quickly your body makes cerebrospinal fluid (CSF). It specifically targets a tissue in the brain called the choroid plexus, acting like a brake on fluid production. This decrease in fluid volume directly lowers the overall pressure inside your skull [1].
How It Works in the Brain
Cerebrospinal fluid (CSF) is the clear liquid that surrounds and protects your brain and spinal cord. It is constantly produced by a specialized brain structure known as the choroid plexus [2].
In people with IIH, the pressure from this fluid is abnormally high. Acetazolamide works by blocking an enzyme called carbonic anhydrase, which the choroid plexus uses to manufacture CSF [1]. By inhibiting this enzyme, acetazolamide reduces the amount of new fluid pumped into the spaces around your brain, which effectively decreases your intracranial pressure [3]. Research shows it may also influence how sodium and potassium move in the brain’s tissues, further slowing fluid secretion [4].
The Diuretic Effect
You might hear acetazolamide described as a “water pill” or a mild diuretic because it also acts on your kidneys, increasing urine output. However, its primary success in treating IIH isn’t because it makes you urinate more. Instead, it is the proven first-line treatment specifically because of its direct action on the brain’s choroid plexus to reduce fluid creation [3].
What to Expect: Side Effects and Adherence
Because acetazolamide affects enzymes throughout your body, you will likely experience some day-to-day side effects. The most common include:
- Paresthesia: A tingling, “pins and needles” sensation or numbness in your fingers, toes, and face.
- Dysgeusia: An altered sense of taste, making foods—especially carbonated drinks—taste metallic or flat.
- Fatigue: Feeling unusually tired or sluggish.
These symptoms are very common and not a sign that the medication is harming you. To help your body adjust, your doctor will likely start you on a lower dose and gradually increase it over time.
Taking acetazolamide exactly as prescribed is a critical part of your treatment plan. Major clinical trials, such as the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), have proven that using this medication consistently significantly improves vision and lowers the pressure inside the skull [5][6].
Monitoring and Hydration
Because it also acts on your kidneys, acetazolamide can cause changes in your blood chemistry, such as metabolic acidosis (a condition where your blood becomes slightly too acidic) [7]. It can also increase your risk of developing kidney stones over time [8].
To stay safe and manage these risks:
- Stay Hydrated: Drinking plenty of water is one of the best ways to help prevent kidney stones while taking this medication.
- Get Blood Work Done: Your healthcare team might periodically monitor your blood work or kidney health to check your electrolyte levels and ensure your blood isn’t becoming too acidic [9].
Common questions in this guide
How does acetazolamide lower pressure in the brain?
Will acetazolamide make my hands and feet tingle?
Why do sodas and carbonated drinks taste bad when taking Diamox?
What blood tests or monitoring do I need while on acetazolamide?
How can I prevent kidney stones while taking acetazolamide?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Are there specific blood tests or monitoring schedules I need while taking acetazolamide?
- 2.Should I be taking potassium supplements or making dietary changes while on this medication?
- 3.What side effects (like severe tingling or fatigue) are expected, and at what point should I contact you about them?
- 4.How will we know if the current dose of acetazolamide is effectively lowering my intracranial pressure?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (9)
- 1
Utility of acetazolamide for headaches in the setting of pulmonary arterial hypertension - A case report.
Nabaty NL, Tobin JA
Headache 2025; (65(5)):892-896 doi:10.1111/head.14909.
PMID: 39995285 - 2
Acetazolamide for Idiopathic Intracranial Hypertension: An Up-to-Date Review in 2025.
Naqvi J, Wall M, Chung SM, et al.
Eye and brain 2025; (17()):125-136 doi:10.2147/EB.S492845.
PMID: 41054617 - 3
[Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].
Aguilar-Pérez M, Henkes H
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2015; (112(10)):821-7 doi:10.1007/s00347-015-0136-1.
PMID: 26400795 - 4
Acetazolamide lowers intracranial pressure and modulates the cerebrospinal fluid secretion pathway in healthy rats.
Uldall M, Botfield H, Jansen-Olesen I, et al.
Neuroscience letters 2017; (645()):33-39 doi:10.1016/j.neulet.2017.02.032.
PMID: 28219789 - 5
Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management.
Wang MTM, Bhatti MT, Danesh-Meyer HV
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022; (95()):172-179 doi:10.1016/j.jocn.2021.11.029.
PMID: 34929642 - 6
Effectiveness of Topiramate Versus Acetazolamide in the Management of Idiopathic Intracranial Hypertension: ASystematic Review and Meta-Analysis.
Almaqhawi A, Alokley A, Alamri R, et al.
Medicina (Kaunas, Lithuania) 2025; (61(3)) doi:10.3390/medicina61030450.
PMID: 40142261 - 7
Acetazolamide-induced metabolic acidosis in pediatric idiopathic intracranial hypertension: associations with bone mineral density, growth, and kidney function.
Baltu D, Taş N, Alıcı N, Yılmaz A
Pediatric nephrology (Berlin, Germany) 2026; doi:10.1007/s00467-026-07431-2.
PMID: 42350680 - 8
Assessing the Risk of Kidney Stone Development in Patients With Idiopathic Intracranial Hypertension Treated With Carbonic Anhydrase Inhibitors.
Muayad J, Alryalat SA, Al Deyabat O, et al.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2025; (45(4)):420-425 doi:10.1097/WNO.0000000000002307.
PMID: 39726109 - 9
The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension.
Bulkowstein Y, Nitzan-Luques A, Schnapp A, et al.
Pediatric nephrology (Berlin, Germany) 2024; (39(1)):185-191 doi:10.1007/s00467-023-06084-9.
PMID: 37480382
This page provides educational information about how acetazolamide works for Idiopathic Intracranial Hypertension. It does not replace professional medical advice, and you should always consult your doctor regarding your specific treatment plan and side effects.
Get notified when new evidence is published on Idiopathic intracranial hypertension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.